Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., et al. (1992). Schizophrenie: Manifestationen, Häufigkeit und Verlauf in verschiedenen Kulturen: Eine Zehn-Länder-Studie der Weltgesundheitsorganisation. Psychological Medicine, Mo Suppl 20, 97.
„Interestingly, 24- to 36-month medication use was a significant marker (0.13 SNAP units), not of beneficial outcome, but of deterioration. That is, participants using medication in the 24- to 36-month period actually showed increased symptomatology during that interval relative to those not taking medication."
P.S. Jensen et al.: 3-Year Follow-up of the NIMH MTA Study. Journal of the American Academy of Child and Adolescent Psychiatry, 46:8, Aug. 2007, p 996
J. Moncrieff et al.: The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry; 2022: https://doi.org/10.1038/s41380-022-01661-0
R. Whitaker - Mad in America - Bad science, Bad Medicine and the Enduring Mistreatment of the Mentally ill. Basic Books, 2nd Edition, 2010.
R. Whitaker - Anatomie einer Epidemie - Wenn Psychopharmaka krank machen, Kohlhammer Sachbuch, 2026.
